LignaMed Overview

  • Founded
  • 2013
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 3

LignaMed General Information


Developer of molecule therapy for the treatment for cancer. The company develops therapeutics from flaxseed derivatives to amplify effects of chemotherapy and radiation treatment on cancer cells.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Healthcare
Primary Office
  • Philadelphia, PA
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

LignaMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 10-Mar-2015 Completed Startup
2. Accelerator/Incubator 04-Mar-2015 Completed Startup
1. Grant 18-Jan-2014 $825K Completed Startup
To view LignaMed’s complete valuation and funding history, request access »

LignaMed Executive Team (3)

Name Title Board Seat Contact Info
Thais Sielecki Chief Scientific Officer
Melpo Christofidou Solomidou Ph.D Founder & Chairman of Scientific Advisory Board
Jim Harris Chief Executive Officer
To view LignaMed’s complete executive team members history, request access »

LignaMed Board Members (2)

Name Representing Role Since
Dora Mitchell Ph.D UPstart Board Member 000 0000
Melpo Christofidou Solomidou Ph.D LignaMed Founder & Chairman of Scientific Advisory Board 000 0000
To view LignaMed’s complete board members history, request access »

LignaMed Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
UPstart Accelerator/Incubator 000 0000 000000 0
Science Center Accelerator/Incubator 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
To view LignaMed’s complete investors history, request access »